Published in J Chem Neuroanat on January 01, 2005
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res Treat (2005) 2.75
Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol (2002) 2.27
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. Int J Cancer (2006) 2.16
Childhood obesity is associated with maternal smoking in pregnancy. Eur J Pediatr (2002) 1.77
Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci (2009) 1.76
The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detect Prev (2007) 1.69
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology (2005) 1.67
Routine complete capsular closure during hip arthroscopy. Arthrosc Tech (2013) 1.64
Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst (2002) 1.58
Identification of aminobiphenyl derivatives in commercial hair dyes. Chem Res Toxicol (2003) 1.58
Meat intake and cooking techniques: associations with pancreatic cancer. Mutat Res (2002) 1.57
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst (2002) 1.56
Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res (2002) 1.53
Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci U S A (2006) 1.52
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol Biomarkers Prev (2006) 1.45
Osteochondral lesions of the talus: effect of defect size and plantarflexion angle on ankle joint stresses. Am J Sports Med (2012) 1.44
Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk. Mutat Res (2002) 1.44
Nitrative and oxidative stress in toxicology and disease. Toxicol Sci (2009) 1.44
Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetics (2002) 1.35
Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci (2010) 1.35
Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci (2009) 1.33
Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey. Neurotoxicol Teratol (2011) 1.30
Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells. Prostate (2008) 1.29
Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci (2006) 1.24
Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system. Anesth Analg (2008) 1.23
DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair. Nucleic Acids Res (2007) 1.23
Dietary intake of heterocyclic amines and benzo(a)pyrene: associations with pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.23
Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol Sci (2002) 1.15
Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol (2006) 1.14
Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev (2006) 1.14
Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol (2005) 1.13
Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors (2003) 1.12
Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev (2004) 1.09
Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells. Mol Divers (2006) 1.09
Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants. Urology (2009) 1.08
Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. Int J Cancer (2003) 1.07
Processed meat intake, CYP2A6 activity and risk of colorectal adenoma. Carcinogenesis (2007) 1.07
Evidence of capsular defect following hip arthroscopy. Knee Surg Sports Traumatol Arthrosc (2013) 1.06
Neurobehavioral assessment: a survey of use and value in safety assessment studies. Toxicol Sci (2003) 1.04
Mechanistic toxicity evaluation of uncoated and PEGylated single-walled carbon nanotubes in neuronal PC12 cells. ACS Nano (2011) 1.03
Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis. Carcinogenesis (2006) 1.03
Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype. Pharmacogenet Genomics (2006) 1.02
Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. Arch Biochem Biophys (2007) 1.02
Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate. Proc Natl Acad Sci U S A (2011) 1.02
Mitochondrial mutagenesis and oxidative stress in human prostate cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2004) 1.02
Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS- and ATP-dependent pathways. Int J Cancer (2005) 1.01
Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity. Toxicol Sci (2010) 1.00
Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota. Nutr Cancer (2009) 1.00
Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke. Carcinogenesis (2003) 1.00
Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology (2005) 0.99
The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol Appl Pharmacol (2009) 0.99
Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis. Carcinogenesis (2003) 0.98
Methyl deficiency, alterations in global histone modifications, and carcinogenesis. J Nutr (2007) 0.98
Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model. PLoS One (2013) 0.97
CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl. Int J Cancer (2006) 0.97
Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry. Chem Res Toxicol (2010) 0.97
Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene. Carcinogenesis (2008) 0.96
Protective effects of 7-nitroindazole on ketamine-induced neurotoxicity in rat forebrain culture. Neurotoxicology (2008) 0.96
CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev (2005) 0.96
Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity. Pharmacogenet Genomics (2005) 0.95
Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer. Toxicology (2002) 0.95
A new clue to glaucoma pathogenesis. Am J Med (2003) 0.94
Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin. Mol Pharmacol (2007) 0.94
Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet. Mol Nutr Food Res (2010) 0.94
Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mutagen (2002) 0.94
A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: microPET Imaging using 18F-annexin V. Toxicol Sci (2009) 0.94
Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture. Toxicol Sci (2012) 0.93
In silico drug repositioning: what we need to know. Drug Discov Today (2012) 0.93
Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats. Cell Cycle (2008) 0.91
SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev (2004) 0.91
Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis. Toxicol Sci (2013) 0.91
Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form. Pharmacogenetics (2004) 0.90
A microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools. BMC Bioinformatics (2005) 0.90
Phenotypic CYP2A6 variation and the risk of pancreatic cancer. JOP (2009) 0.90
Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations. Neurotoxicology (2003) 0.90
Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice. Hepatology (2012) 0.89
Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas. Nutr Cancer (2007) 0.88
Preclinical assessment of ketamine. CNS Neurosci Ther (2013) 0.88
Anesthetic-induced oxidative stress and potential protection. ScientificWorldJournal (2010) 0.88
Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study. Ann N Y Acad Sci (2002) 0.88
Incorporating children's toxicokinetics into a risk framework. Environ Health Perspect (2004) 0.88
A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer. Hum Mutat (2008) 0.88
A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine. Chem Res Toxicol (2010) 0.87
Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines. Chem Res Toxicol (2004) 0.86
The genetic toxicology of methylphenidate hydrochloride in non-human primates. Mutat Res (2008) 0.86
Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk. Cancer Causes Control (2010) 0.86
Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals. Arch Biochem Biophys (2002) 0.86
Changes in mouse liver protein glutathionylation after acetaminophen exposure. J Pharmacol Exp Ther (2011) 0.86
Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. Carcinogenesis (2003) 0.85
Sulfotransferase 4A1. Int J Biochem Cell Biol (2007) 0.85
Sequence variants in antioxidant defense and DNA repair genes, dietary antioxidants, and pancreatic cancer risk. Int J Mol Epidemiol Genet (2011) 0.85
A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.85
Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities. Environ Mol Mutagen (2004) 0.85
Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population. Toxicol Sci (2009) 0.85
Lack of association between Caucasian lung cancer risk and O6-methylguanine-DNA methyltransferase-codon 178 genetic polymorphism. Lung Cancer (2004) 0.85
Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis. Mol Carcinog (2007) 0.85
Variation in cyclooxygenase expression levels within the colorectum. Mol Carcinog (2003) 0.84